United Services Automobile Association Genfit S.A. Transaction History

United Services Automobile Association

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$14.92 - $19.94 $597,546 - $798,597	-40,050 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$19.74 - $25.65 $45,402 - $58,995	-2,300 Reduced 5.43%	40,050 $791,000
Q1 2019 May 13, 2019	BUY	$22.17 - $24.0 $938,899 - $1.02 Million	42,350 New	42,350 $1.02 Million

77.7K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $212M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.